Here come the first true digital health ipos. We’ve got 5 burning questions — and some answers

SAN FRANCISCO — Silicon Valley venture capital investors and Wall Street investment firms got in early on a new generation of slick and savvy health-tech startups. Now, anyone with an

internet connection will be able to bet on them, too. The question is whether the sector can live up to its hype. Two leading companies in the sector — diabetes coaching startup Livongo and

hospital data cruncher Health Catalyst — went public on the Nasdaq on Thursday. Both stocks popped in early trading Thursday morning after listing their shares on Wednesday evening slightly

above the range they had forecasted. Silicon Valley-based Livongo priced $12.7 million shares at $28, and Salt Lake City-based Health Catalyst priced 7 million shares at $26. STAT+ Exclusive

Story Already have an account? Log in THIS ARTICLE IS EXCLUSIVE TO STAT+ SUBSCRIBERS UNLOCK THIS ARTICLE — AND GET ADDITIONAL ANALYSIS OF THE TECHNOLOGIES DISRUPTING HEALTH CARE — BY

SUBSCRIBING TO STAT+. Already have an account? Log in Individual plans Group plans View All Plans To read the rest of this story subscribe to STAT+. Subscribe